Scailyte raises €7.2M Series A round
5 December 2023· Basel, Switzerland· health, precision_medicine, ai, biotech, pure_software, b2b
expand presence in the US market, seeking further partnerships with biotech and pharma companies in the precision oncology space, accelerating Scailyte's impact in the immuno-oncology landscape, expanding business partnerships and market footprint, to promote the discovery of new clinically relevant biomarker signatures
About Scailyte
Stage
Series A
Headquarters
Basel, Switzerland
Founded
2017
Team Size
21–50
Sectors
healthprecision_medicineaibiotechpure_softwareb2b